How All Sponsors Can Benefit from a Synchronized Outsourcing Strategy
The ebb and flow of a pharmaceutical or biotechnology company’s clinical development portfolio places an emphasis on ensuring that the resources applied can similarly ebb and flow in synchrony with the demand of their portfolio. Historically, in addition to building some capability with internal staff, companies have relied on two possible outsourcing models to provide that synchrony. The first is the classic Clinical Research Organization model (CRO) whose variability is directly related to outsourced projects.
PRA in China 中国
结合全球 CRO 公司的专业知识与本土经验，我们能为全世界提供最高水准的临床开发服务。
PRA is the Industry Leader in Workforce Transformation
PRA Health Sciences values employees who possess the knowledge and expertise that comes from working with our pharma partners.